Euroopa Liit - eesti - EMA (European Medicines Agency)

astrazeneca ab - osimertinib mesilate - kartsinoom, mitteväikerakk-kopsu - muud antineoplastilised ained, protein kinase inhibiitorid - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.

Eesti - eesti - Ravimiamet

medochemie limited - aripiprasool - tablett - 20mg 14tk; 20mg 90tk; 20mg 84tk; 20mg 28tk; 20mg 56tk

Eesti - eesti - Ravimiamet

medochemie limited - aripiprasool - tablett - 5mg 28tk; 5mg 56tk; 5mg 84tk; 5mg 14tk; 5mg 30tk; 5mg 60tk

Eesti - eesti - Ravimiamet

medochemie limited - aripiprasool - tablett - 30mg 84tk; 30mg 56tk; 30mg 14tk; 30mg 60tk; 30mg 30tk

Eesti - eesti - Ravimiamet

medochemie limited - aripiprasool - tablett - 15mg 60tk; 15mg 14tk; 15mg 30tk; 15mg 90tk; 15mg 28tk

Eesti - eesti - Ravimiamet

medochemie limited - aripiprasool - tablett - 10mg 56tk; 10mg 30tk; 10mg 90tk; 10mg 84tk; 10mg 14tk

Eesti - eesti - Ravimiamet

intracare b.v. - vask+tsink - geel - 40mg+40mg 1g 430g 1tk

Eesti - eesti - Ravimiamet

andermatt biovet gmbh - oksaalhape - taru ravimpulber - 1,43g 200g 1tk; 1,43g 2g 50tk; 1,43g 75g 1tk

Euroopa Liit - eesti - EMA (European Medicines Agency)

seqirus gmbh - gripi viiruse pinna antigeeni (hemaglutiniini ja neuraminidaasi), inaktiveeritud järgmisi tüvesid:a/california/7/2009 (h1n1)pdm09 - nagu tüvi(a/brisbane/10/2010, wild-type)/Šveits/9715293/2013 (h3n2) - nagu tüvi(a/lõuna-austraalia/55/2014, wild-type)b/phuket/3073/2013–nagu tüvi(b/utah/9/2014, wild-type) - influenza, human; immunization - vaktsiinid - gripiprofülaktika täiskasvanutel, iseäranis nendel, kellel kaasneb sellega seotud tüsistused. optaflu tuleks kasutada vastavalt euroopa liidu arendus.

Eesti - eesti - Ravimiamet

medochemie limited - linesoliid - õhukese polümeerikattega tablett - 600mg 100tk; 600mg 20tk; 600mg 14tk; 600mg 10tk; 600mg 24tk; 600mg 60tk; 600mg 50tk; 600mg 30tk